KOREDIFY Trademark

Trademark Overview

On Wednesday, March 19, 2025, a trademark application was filed for KOREDIFY with the United States Patent and Trademark Office. The USPTO has given the KOREDIFY trademark a serial number of 79425633. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, June 12, 2025. This trademark is owned by NOVO NORDISK HEALTH CARE AG. The KOREDIFY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of hematological conditions, pharmaceutical preparations for the treatment of anemia, pharmaceutical preparations for the treatment of sickle cell disease.
koredify

General Information

Serial Number79425633
Word MarkKOREDIFY
Filing DateWednesday, March 19, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, June 12, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing0 - NOT AVAILABLE
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of hematological conditions, pharmaceutical preparations for the treatment of anemia, pharmaceutical preparations for the treatment of sickle cell disease.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 12, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNOVO NORDISK HEALTH CARE AG
Party Type10 - Original Applicant
Legal Entity Type98 - Unknown
AddressCH

Trademark Events

Event DateEvent Description
Thursday, June 12, 2025SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

koredify pharmaceutical treatment preparations cell disease sickle conditions hematological anemia